Orforglipron|Wegovy|Retatrutide The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like Zepbound (tirzepatide) and Wegovy (semaglutide). But as we move through 2026, the “second generation” of obesity treatments has arrived, offering more convenience and, in some cases, power that rivals bariatricContinueContinue reading “Update: New Options for Weight Loss”
